Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
REV-MED Inc. logo — Innovating regenerative medicine and bioengineering technolo...

REV-MED Inc.

Innovating regenerative medicine and bioengineering technologies for a healthier future

Founded 2009 Korea South Korea South 7 employees Biotechnology, Health Care

General Information

Company Name REV-MED Inc.
Founded Year 2009
Location Korea South Korea South
Employees 7
Industries Biotechnology, Health Care
Social

BounceWatch is an independent company data service, not affiliated with REV-MED Inc.. To contact REV-MED Inc., visit rev-med.co.kr.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does REV-MED Inc. compare?

A PDF of REV-MED Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting REV-MED Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About REV-MED Inc.

REV-MED Inc. is a pioneering biotech company founded in 2009 with a vision to revolutionize regenerative medicine and bioengineering technologies for a healthier future. With a strong focus on Biotechnology and Health Care industries, the company is at the forefront of the healthcare market, equipped with advanced technology infrastructure. Based in South Korea, REV-MED Inc. has positioned itself as a leader in innovative healthcare solutions. As of now, there is no publicly disclosed information available regarding their last investment and associated investors. The company's slogan, "Innovating regenerative medicine and bioengineering technologies for a healthier future," encapsulates their commitment to pushing boundaries and making a significant impact in the healthcare industry.

Business keywords: biotech, regenerative medicine, bioengineering, technology infrastructure, innovation, health solutions, biomedical engineering

No funding data available for REV-MED Inc. yet.

REV-MED Inc. Alternatives & Competitors

View All Alternatives
REV-MED Inc. vs
Chimeron Bio
Chimeron Bio United States

Redefining genetic medicine with future-forward RNA technology designed to deliver meaningful patien...

Angel
12 employees
Biotechnology, Health Care
REV-MED Inc. vs
Cartilage Inc.
Cartilage Inc. United States

Real engineered cartilage for real healing.

Grant
12 employees
Biotechnology, Health Care
REV-MED Inc. vs
Innervace
Innervace United States

Anatomically-Inspired Living Pathways: Realizing the Potential of Regenerative Medicine

Series A
3 employees
Biotechnology, Health Care
View all alternatives

FAQ About REV-MED Inc.

Innovating regenerative medicine and bioengineering technologies for a healthier future
REV-MED Inc. was founded in 2009.
REV-MED Inc. is headquartered in Korea South.
REV-MED Inc. operates in Biotechnology and Health Care. Its work centres on biotech, regenerative medicine, bioengineering and technology infrastructure.
REV-MED Inc. has approximately 7 employees.
Top alternatives and competitors to REV-MED Inc. include Chimeron Bio, Cartilage Inc., Innervace, MICA Biosystems, Xi'an Particle Cloud Biotechnology Co., Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
REV-MED Inc. and Chimeron Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for REV-MED Inc., https://bouncewatch.com/company/rev-med-inc, updated 25 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout